Results from the pegylated versus standard interferon- -2b/ribavirin combination study raise a number of issues concerning optimum dosage and duration of treatment with the pegylated formulation.

Introduction How Serious is the Problem? Treatment Options Increasing Pegylation Increases Half-Life... References ...

Janssen and colleagues have recently shown that pegylated interferon α-2b is equally as effective as combination therapy using pegylated interferon α-2b and lamivudine in patients with hepatitis ...

Figure 1: Worldwide prevalence of hepatitis C in millions. HCV patients currently receive a combination of pegylated interferon-alfa (PEG–IFN) — either 2a (Roche's Pegasys) or 2b (Schering-Plo ...

with pegylated interferon alfa-2α (IFN) and ongoing nucleos(t)ide analogue (NA) therapy. The trial demonstrated that six doses of imdusiran and 24 weeks of IFN led to a functional cure in 50% of ...

Out of five medication regimens given for 48 weeks in the open-label Piranga study, combination xalnesiran plus pegylated interferon alfa-2a (Pegasys) therapy had the best results when it came to ...